Related references
Note: Only part of the references are listed.EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban
Sean Platton et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2019)
Influence of anticardiolipin and anti-β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
Laura Vanoverschelde et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
False-positive lupus anticoagulant results by DRVVT in the presence of rivaroxaban even at low plasma concentrations
M. E. Martinuzzo et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2018)
Use of direct oral anticoagulants in antiphospholipid syndrome
H. Cohen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Simple method for removing DOACs from plasma samples
T. Exner et al.
THROMBOSIS RESEARCH (2018)
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
L. Andreoli et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Establishing reference intervals in the coagulation laboratory
D. D. Castellone
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2017)
Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients
Gary W. Moore et al.
BLOOD COAGULATION & FIBRINOLYSIS (2016)
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
Johanna Gebhart et al.
BLOOD (2015)
Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism
D. R. J. Arachchillage et al.
THROMBOSIS RESEARCH (2015)
Antiphospholipid antibody testing and standardization
K. M. J. Devreese
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2014)
Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH
K. M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Diagnosis of antiphospholipid syndrome in routine clinical practice
C. Gardiner et al.
LUPUS (2013)
Measurement of Lupus Anticoagulants: An Update on Quality in Laboratory Testing
Murray Adams
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies
Michael D. Lockshin et al.
ARTHRITIS AND RHEUMATISM (2012)
Guidelines on the investigation and management of antiphospholipid syndrome
David Keeling et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Shannon M. Bates et al.
CHEST (2012)
Internal Quality Control and External Quality Assurance in Testing for Antiphospholipid Antibodies: Part II-Lupus Anticoagulant
Emmanuel J. Favaloro et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time
G. M. A. Van Os et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Lupus Anticoagulant Testing Performance and Practices by North American Clinical Laboratories
Francine R. Dembitzer et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist
Kiran Parmar et al.
BLOOD COAGULATION & FIBRINOLYSIS (2009)
Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome
Katrien Devreese et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Update of the guidelines for lupus anticoagulant detection
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Are laboratories following published recommendations for lupus anticoagulant testing?
Karen A. Moffat et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Reporting of cardiac troponin - Problems with the 99th population percentile
Peter E. Hickman et al.
CLINICA CHIMICA ACTA (2007)
Laboratory testing for lupus anticoagulants: A review of issues affecting results
Armando Tripodi
CLINICAL CHEMISTRY (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants
GW Moore et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Lupus anticoagulant testing: improvements in performance in a UKNEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods
I Jennings et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies
S Donohoe et al.
LUPUS (2002)
Share Paper
